4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-14-003737
$ACADCIK 0001070494operating
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 6:29 PM ET
Size
9.0 KB
Accession
0001415889-14-003737
Insider Transaction Report
Form 4
BORER MICHAEL T
Director
Transactions
- Exercise/Conversion
Common Stock
2014-11-26$11.00/sh+15,000$165,000→ 15,000 total - Sale
Common Stock
2014-11-26$30.05/sh−15,000$450,765→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2014-11-26−15,000→ 0 totalExercise: $11.00Exp: 2015-09-08→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2013.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.18 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]50% of the shares subject to the stock option vested and became exercisable on September 9, 2006, and 50% of the shares subject to the stock option vested and became exercisable on September 9, 2007.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 6:29 PM ET
- Size
- 9.0 KB